News Releases:
- 11 Sept 2024; Innovotech enters LOI to acquire Keystone
- 20 Aug 2024; Q2-2024 Results
- 16 July 2024; 2024 Annual General and Special Meeting Results
- 18 June 2024; InnovoSIL(TM)-1 Antimicrobial Silver Shown to Kill Medically Important Viruses
- 21 May 2024; Q1-2024 Results
- Apr 24, 2024, Annual Innovotech Reports a Loss for Fiscal 2023
- Dec 12, 2023, Innovotech CFO
- Nov 28, 2023, Innovotech AICE Grant
- Aug 25, 2023, Innovotech Closes Majority Stake in Nou Life Skincare Technology
- Aug 15, 2023, Innovotech Reports a Profitable Second Quarter Ended June 30th, 2023
- Aug 1, 2023, Notice of Grant of Third Party Option by Control Person
- July 17, 2023, Innovotech Appoints Dr. Craig Milne as Chief Executive Officer
- May 23, 2023, Innovotech Reports a Loss for its First Quarter Ended March 31, 2023
- May 15, 2023, InnovoSIL TM-1 Antimicrobial Silver Works Against Candida auris and Superbugs
- Apr 25, 2023, Innovotech Reports a Loss for Fiscal 2022
- Nov 15, 2022, Innovotech Reports a Profitable Third Quarter and Sees Its MBEC Assay Plate Used In Space
- Oct 25, 2022, Innovotech Inc. Grants 150,000 Incentive Stock Options and Reports Retirement of a Director
- August 16, 2022, Innovotech reports a loss for the first 6 months to June 30th, 2022
- May 24, 2022, Innovotech reports decreased net profit in the first 3 months of 2022 to March 31st, (Q1)
- April 26, 2022, Innovotech reports increased net profit in 2021
- January 21, 2022, Termination of Collaboration Agreement for InnovoSIL™-1 Antimicrobial Silver
- November 16, 2021, Innovotech reports nine-month results to September 30, 2021
- August 24, 2021, Innovotech reports six-month results to June 30, 2021
- August 2, 2021, Notice of Meeting and Record Date
- May 25 , 2021, Innovotech reports profitable first quarter (Q1) to March 31st
- April 20, 2021, Innovotech Inc. News Release Fiscal YE 2020
- April 14, 2021, Innovotech announces appointment of Dr. Tyler Boone as COO
- March 8, 2021, Alan C. Savage Files Early Warning Report
- Feb 23, 2021, Innovotech Announces TSX Venture Exchange Final Approval of CanBiocin Debenture Acquisition
- January 19, 2021, Approval of Innovotech acquisition of a 60% interest in Nou Life Sciences Inc.
- January 18, 2021, Innovotech reports termination of agreement for acquisition of shares of listed health sector companies
- January 5, 2021, Innovotech reports acquisition of shares of listed health sector companies
- November 12, 2020, Innovotech announces third quarter results to September 30th, 2020
- October 20, 2020, Innovotech announces the grant of stock options
- October 16, 2020, Innovotech acquires 8% CanBiocin Inc. convertible debenture
- September 2, 2020, Press release announcing closing of private placement (IOT)
- August 24, 2020, Innovotech News Release August 24 announcing private placement (IOT)
- August 18, 2020, Innovotech Inc News Release Nou Life Sciences August 18 2020
- August 12, 2020, Innovotech Inc News Release Q2 2020
- July 14, 2020, Innovotech InnovoSIL-1 Collaboration Agreement News Release
- April 28, 2020, Innovotech Inc. News Release Fiscal YE 2019
- February 20, 2020, Innovotech Submits New Provisional Patent Application
- December 16, 2019, Innovotech Appoints New Board Member Dr. Karen Farkas
- December 10, 2019, Innovotech Reviews Progress, Redirection And Innovation
- November 20, 2019, Innovotech Reports Profitable Third Quarter
- October 23, 2019, Early Warning Report
- October 18,2019, Patent Being Granted
- August 20, 2019, Reports 3 and 6-month Results to June 30, 2019
- July 26, 2019, Notice of Allowance of a US Patent
- July 19, 2019, Changes to Board of Directors
- July 15, 2019, Amended Terms of Line of Credit
- May 17, 2019, Innovotech 2018 First Quarter Financial Results
- April 26, 2019, Innovotech Reports 2018 Financial Results
- March 31, 2019, Innovotech Reports 2019 First Quarter Financial Results